•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Lilly vs. Pfizer: Which Drugmaker Has Stronger Growth Prospects?
5 High-Yield Dividend Stocks Retirees Can Buy for Under $50 a Share
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
4 Dividend Stocks Wall Street Gave Up On With Balance Sheets Built to Recover
Pfizer Yields 6.25%. These 3 Dividend Stocks Pay More Than a 1-Year Treasury Bill
4 Yield Traps Paying Over 6% That Retirees Should Watch Out For
PFE Inks $2.6B Licensing Deal With Chinese Biotech for CAR-T Therapies
Can New Products and Acquisitions Revive Pfizer's Growth Story?
Forget JEPI: 4 High-Yield Dividend Stocks Retirees Should Own Instead
4 S&P 500 Dividend Stocks Paying Shareholders More Than Their Free Cash Flow
Pfizer Will Pay Its 352nd Straight Quarterly Dividend on Dec. 7. Here's What It Would Take to Break the Streak.
Pfizer: The Patent Cliff Fears Are Overblown
4 Dividend Stocks Yielding Over 6% That Fit a Roth IRA
3 High-Yield Dividend Stocks Down Nearly 30% or More in 5 Years
Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases
Pfizer: Strong Growth Momentum And Attractive Valuation Support A Strong Buy
Wall Street Forgot These 3 Dividend Stocks — Now They Pay Over 5%
Johnson & Johnson vs. Pfizer: Consistency vs.
5 Safe High-Yield Dividend Stocks Boomers Should Buy Before Year-End
5 “Forever Income” Dividend Stocks Yielding 5% and More for Boomers